2005 2004 4% 1 2850 2005 12% 13 12 11 10 9 8 7 6 5 4 2 2 1 0 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 2025 65 25% 2006 7
10 1.1 1.2 2.1 3.6 3.8 4.7 5.2 5.3 6.9 8.2 11.6 12.1 14.5 19.3 19.7 25.7 31.7 42.1 6000 2 1. 2. 3. 4. 5. 6. 1. 2. ISO HACCP 3. 4. 5. 5% 15% 17% 2900 8 2006
CoQ10 α 20% 5% 2005 1050 5% 2200 5% 9600 5% 1 2850 4% 2005 1 CoQ10 CoQ10 2 3 α 4 α 5 6 C 7 8 9 10 1984~1987 1988~1991 1993~1996 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. JHFA 55 2006 9
JHFA - EPA DHA E C β- 1984 1984~1987 1988~1991 1993~1996 1988 2 1988 6 1988 8 1989 3 1992 7 1992 10 1993 6 2001 3 2001 4 2001 12 2002 7 2003 1 2003 4 2004 2 2004 4 60 2004 9CoQ10 2005 1 2005 2α- 2006 5 569 6,000 2000~2005 25 2000-10 2006
2002- CoQ10 2004- CoQ10 - α-β- 2005- CoQ10 - α- 2005 25 (1) (A) 150 β- GRAS phicocyanin zeaxanthin (B) 1,520t 1,010t 374t 34% (2) 2004 4 350 (3) 100 (3-methyl-D-gucoside) (4) 1t 30-50 1-7 2006 11
(5) 420 250 160 10 82 (6) β-glucan lignan (7) 732t 14 10 B 1.6% biopten (R) (8) 150t200 (9) 1998 400 500t 3,000~4,000 (10) 200t 8 2 (11) 200 DNA RNA 80t (12) 1,700t 2,200-2300t 25% (20%) (55%) 12 2006
(13) (14)(Ceramide) Ceramide 15 Ceramide (15) (Fucoidan) (Fucose) (16) LDL (17)(PS) PS 40t 70% 5t (18)CoQ10 2001 CoQ10 2004 9 230 35t (19) - - CoQ10 2001 CoQ10 2004 80t 2005 150t LDL 2006 13
(20)α- α- 100mg 2004 50 t 2005 100 (21) 1987 130 5000 FU/g (22) OPC (Oligomellic proanthoapamin) 3.5t (23) 160 N24%6% 5ppm 20mg (24) 300 35t 30 mg (25) (A B C) γ-glutamyl-s-allyl cystein 8-1 14 2006
8-2 CoQ10 α C α- γ- DHA β- (black currant) 8-3 8-4 1. (2005) 2. (1999-2005) 39-45 (3) 3. (2004) 39(7):5-9 2006 15